• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺癌中涉及双特异性磷酸酶6/丝裂原活化蛋白激酶磷酸酶-3的潜在肿瘤抑制途径。

Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer.

作者信息

Furukawa Toru, Sunamura Makoto, Motoi Fuyuhiko, Matsuno Seiki, Horii Akira

机构信息

Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, Japan.

出版信息

Am J Pathol. 2003 Jun;162(6):1807-15. doi: 10.1016/S0002-9440(10)64315-5.

DOI:10.1016/S0002-9440(10)64315-5
PMID:12759238
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1868131/
Abstract

We previously found frequent loss of heterozygosity at 12q21 and 12q22-q23.1 in primary pancreatic cancers, and the DUSP6/MKP-3 gene residing in this region at 12q22 lost its expression in the great majority of pancreatic cancer cell lines. The DUSP6/MKP-3 protein is a dual-specificity phosphatase that dephosphorylates the active form of ERK, making a feedback loop to control ERK activity. Gain-of-function mutations of KRAS2 occur in the great majority of pancreatic cancer cells, and loss of expression of DUSP6/MKP-3 may synergistically promote constitutive activation of ERK and uncontrolled cell growth. To study loss of the feedback pathway and its impact on pancreatic cancer cell growth, we first investigated the expression of DUSP6/MKP-3 in primary pancreatic cancer tissues immunohistochemically; we found up-regulation in mildly as well as severely dysplastic/in situ carcinoma cells and down-regulation in invasive carcinoma, especially in the poorly differentiated type. Adenovirus-mediated reintroduction of DUSP6/MKP-3 into cultured pancreatic cancer cells induced strong expression of recombinant DUSP6/MKP-3 and reduction of phosphorylated ERK in a dose-dependent manner based on the multiplicity of infection and resulted in suppression of cell growth. Moreover, analyses by flow cytometry and immunocytochemistry revealed that the exogenous expression of DUSP6/MKP-3 induced apoptosis. These results show that DUSP6 exerts apparent tumor-suppressive effects in vitro and suggest that DUSP6 is a strong candidate tumor suppressor gene at 12q22 locus.

摘要

我们之前发现,原发性胰腺癌中12q21以及12q22 - q23.1区域频繁出现杂合性缺失,位于12q22该区域的双特异性磷酸酶6(DUSP6)/丝裂原活化蛋白激酶磷酸酶 - 3(MKP - 3)基因在绝大多数胰腺癌细胞系中失去表达。DUSP6/MKP - 3蛋白是一种双特异性磷酸酶,可使细胞外信号调节激酶(ERK)的活性形式去磷酸化,从而形成一个反馈环来控制ERK活性。绝大多数胰腺癌细胞中发生KRAS2功能获得性突变,而DUSP6/MKP - 3表达缺失可能协同促进ERK的组成性激活及细胞的失控生长。为了研究该反馈通路的缺失及其对胰腺癌细胞生长的影响,我们首先通过免疫组织化学方法研究了原发性胰腺癌组织中DUSP6/MKP - 3的表达;我们发现,在轻度以及重度发育异常/原位癌细胞中DUSP6/MKP - 3表达上调,而在浸润性癌中表达下调,尤其是在低分化型癌中。腺病毒介导的DUSP6/MKP - 3重新导入培养的胰腺癌细胞,基于感染复数以剂量依赖的方式诱导重组DUSP6/MKP - 3的强烈表达以及磷酸化ERK的减少,并导致细胞生长受到抑制。此外,通过流式细胞术和免疫细胞化学分析表明,DUSP6/MKP - 3的外源性表达诱导细胞凋亡。这些结果表明,DUSP6在体外发挥明显的肿瘤抑制作用,并提示DUSP6是位于12q22位点的一个强有力的候选肿瘤抑制基因。

相似文献

1
Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer.胰腺癌中涉及双特异性磷酸酶6/丝裂原活化蛋白激酶磷酸酶-3的潜在肿瘤抑制途径。
Am J Pathol. 2003 Jun;162(6):1807-15. doi: 10.1016/S0002-9440(10)64315-5.
2
AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer.极光激酶A(AURKA)是胰腺癌中丝裂原活化蛋白激酶1/细胞外信号调节激酶2(MAPK1/ERK2)的下游靶点之一。
Oncogene. 2006 Aug 10;25(35):4831-9. doi: 10.1038/sj.onc.1209494. Epub 2006 Mar 13.
3
Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis.丝裂原活化蛋白激酶磷酸酶1在前列腺癌中过表达,且与细胞凋亡呈负相关。
Lab Invest. 1997 Jan;76(1):37-51.
4
Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis.丝裂原活化蛋白激酶磷酸酶-1在人类上皮癌发生早期阶段的表达
Am J Pathol. 1996 Nov;149(5):1553-64.
5
Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas.涉及双特异性磷酸酶6/丝裂原活化蛋白激酶磷酸酶-3(DUSP6/MKP-3)功能障碍的不同进展途径在胰腺上皮内瘤变和胰腺导管内乳头状黏液性肿瘤中的作用。
Mod Pathol. 2005 Aug;18(8):1034-42. doi: 10.1038/modpathol.3800383.
6
Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells.腺病毒介导的p53基因转导抑制人胰腺癌细胞中的端粒酶活性,且该作用独立于其对细胞周期阻滞和细胞凋亡的影响。
Clin Cancer Res. 1999 Aug;5(8):2140-7.
7
Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.丝裂原活化蛋白激酶磷酸酶-1在非小细胞肺癌中过表达,是患者预后的独立预测指标。
Clin Cancer Res. 2004 Jun 1;10(11):3639-49. doi: 10.1158/1078-0432.CCR-03-0771.
8
Abrogation of DUSP6 by hypermethylation in human pancreatic cancer.人类胰腺癌中DUSP6因高甲基化而失活。
J Hum Genet. 2005;50(4):159-167. doi: 10.1007/s10038-005-0235-y. Epub 2005 Apr 12.
9
Post-translational regulation of the ERK phosphatase DUSP6/MKP3 by the mTOR pathway.mTOR 通路对 ERK 磷酸酶 DUSP6/MKP3 的翻译后调控
Oncogene. 2008 Jun 12;27(26):3685-91. doi: 10.1038/sj.onc.1211040. Epub 2008 Jan 28.
10
Cellular defense against H2O2-induced apoptosis via MAP kinase-MKP-1 pathway.细胞通过丝裂原活化蛋白激酶-MKP-1途径抵御过氧化氢诱导的细胞凋亡。
Free Radic Biol Med. 2004 Apr 15;36(8):985-93. doi: 10.1016/j.freeradbiomed.2004.01.009.

引用本文的文献

1
Transcriptional regulation of ETV5 by mitogen-activated protein kinase via ETS-1 in human pancreatic cancer cells.在人胰腺癌细胞中,丝裂原活化蛋白激酶通过ETS-1对ETV5进行转录调控。
Sci Rep. 2025 Apr 9;15(1):12128. doi: 10.1038/s41598-025-97166-1.
2
Sustained intestinal epithelial monolayer wound closure after transient application of a FAK-activating small molecule.短暂应用一种能激活黏着斑激酶的小分子后,可实现持续的肠道上皮单层伤口闭合。
PLoS One. 2024 Aug 16;19(8):e0304010. doi: 10.1371/journal.pone.0304010. eCollection 2024.
3
Scoparone attenuates PD-L1 expression in human breast cancer cells by MKP-3 upregulation.滨蒿内酯通过上调MKP-3减弱人乳腺癌细胞中PD-L1的表达。
Anim Cells Syst (Seoul). 2024 Feb 9;28(1):55-65. doi: 10.1080/19768354.2024.2315950. eCollection 2024.
4
Dual-Specificity Phosphatases in Regulation of Tumor-Associated Macrophage Activity.双特异性磷酸酶在调节肿瘤相关巨噬细胞活性中的作用。
Int J Mol Sci. 2023 Dec 16;24(24):17542. doi: 10.3390/ijms242417542.
5
Mutation in the Common Docking Domain Affects MAP Kinase ERK2 Catalysis and Stability.常见对接结构域中的突变影响丝裂原活化蛋白激酶ERK2的催化作用和稳定性。
Cancers (Basel). 2023 May 26;15(11):2938. doi: 10.3390/cancers15112938.
6
Involvement of clusterin expression in the refractory response of pancreatic cancer cells to a MEK inhibitor.簇集蛋白表达参与胰腺癌细胞对 MEK 抑制剂的难治性反应。
Cancer Sci. 2023 May;114(5):2189-2202. doi: 10.1111/cas.15735. Epub 2023 Feb 9.
7
Mechanisms of development and progression of pancreatic neoplasms.胰腺肿瘤发生和发展的机制。
Pathol Int. 2022 Nov;72(11):529-540. doi: 10.1111/pin.13272. Epub 2022 Sep 26.
8
An Integrated Proteomic Strategy to Identify SHP2 Substrates.一种综合蛋白质组学策略,用于鉴定 SHP2 底物。
J Proteome Res. 2022 Oct 7;21(10):2515-2525. doi: 10.1021/acs.jproteome.2c00481. Epub 2022 Sep 14.
9
Suppression of mutant Kirsten-RAS (KRAS)-driven pancreatic carcinogenesis by dual-specificity MAP kinase phosphatases 5 and 6.双特异性丝裂原活化蛋白激酶磷酸酶 5 和 6 抑制突变型 Kirsten-RAS(KRAS)驱动的胰腺肿瘤发生。
Oncogene. 2022 May;41(20):2811-2823. doi: 10.1038/s41388-022-02302-0. Epub 2022 Apr 13.
10
Targeting Phosphatases and Kinases: How to Checkmate Cancer.靶向磷酸酶和激酶:如何“将死”癌症。
Front Cell Dev Biol. 2021 Oct 28;9:690306. doi: 10.3389/fcell.2021.690306. eCollection 2021.

本文引用的文献

1
Focus on pancreas cancer.关注胰腺癌。
Cancer Cell. 2002 Jul;2(1):25-8. doi: 10.1016/s1535-6108(02)00093-4.
2
Solution structure of ERK2 binding domain of MAPK phosphatase MKP-3: structural insights into MKP-3 activation by ERK2.丝裂原活化蛋白激酶磷酸酶MKP-3的ERK2结合域的溶液结构:ERK2激活MKP-3的结构见解
Mol Cell. 2001 Feb;7(2):387-99. doi: 10.1016/s1097-2765(01)00186-1.
3
Characterization of the mutations of the K-ras, p53, p16, and SMAD4 genes in 15 human pancreatic cancer cell lines.15种人胰腺癌细胞系中K-ras、p53、p16和SMAD4基因的突变特征分析。
Oncol Rep. 2001 Jan-Feb;8(1):89-92. doi: 10.3892/or.8.1.89.
4
Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma.12号染色体长臂、17号染色体短臂和18号染色体长臂缺失以及人胰腺导管腺癌中6号染色体长臂/17号染色体短臂和12号染色体长臂/18号染色体长臂的一致性缺失与预后不良的相关性
Am J Gastroenterol. 2000 Aug;95(8):2080-5. doi: 10.1111/j.1572-0241.2000.02171.x.
5
Frequent loss of copy number on the long arm of chromosome 21 in human esophageal squamous cell carcinoma.人类食管鳞状细胞癌中21号染色体长臂上频繁出现拷贝数缺失。
Int J Oncol. 2000 Aug;17(2):245-52.
6
Nitric oxide down-regulates MKP-3 mRNA levels: involvement in endothelial cell protection from apoptosis.一氧化氮下调MKP - 3 mRNA水平:参与内皮细胞抗凋亡保护作用。
J Biol Chem. 2000 Aug 18;275(33):25502-7. doi: 10.1074/jbc.M002283200.
7
Protein phosphatases and the regulation of mitogen-activated protein kinase signalling.蛋白磷酸酶与丝裂原活化蛋白激酶信号传导的调控
Curr Opin Cell Biol. 2000 Apr;12(2):186-92. doi: 10.1016/s0955-0674(99)00075-7.
8
The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal.p42/p44丝裂原活化蛋白激酶途径可防止因细胞贴壁和血清去除所诱导的细胞凋亡。
Mol Biol Cell. 2000 Mar;11(3):1103-12. doi: 10.1091/mbc.11.3.1103.
9
Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms.Ras-MAPK信号通路通过转录依赖性和非依赖性机制促进细胞存活。
Science. 1999 Nov 12;286(5443):1358-62. doi: 10.1126/science.286.5443.1358.
10
B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway.B-Raf通过激活MEK/Erk途径抑制线粒体释放细胞色素c下游的程序性细胞死亡。
Mol Cell Biol. 1999 Aug;19(8):5308-15. doi: 10.1128/MCB.19.8.5308.